PAR 8.00% 23.0¢ paradigm biopharmaceuticals limited..

Paradigm patent rejection, page-22

  1. 572 Posts.
    lightbulb Created with Sketch. 55
    the bolded text saying this action is final seems pretty final. you're talking about an extension - and what extra info do you think PAR would have at hand to overturn? Looks as good as final to me
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.